期刊文献+

他汀类药物治疗心力衰竭的研究进展 被引量:10

下载PDF
导出
出处 《中国心血管病研究》 CAS 2006年第7期552-554,共3页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献14

  • 1[1]Fonarow GC,Horwich TB.Cholesterol and mortality in heat failure:the bad gone good.J Am Coll Cardiol,2003,42:1941-1943.
  • 2[2]Wong M,Staszewsky L,Carretta E,et al.Signs and symptoms in chronic heart failure:Relevance of clinical trial results to point of care-data from Val-HeFT.Eur J Heart Fail,2005,27:[Epub ahead of print].
  • 3[3]McMurray JJ.Val-HeFT:do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?Nat Clin Pract Cardiovasc Med,2005,2:128-129.
  • 4[4]Konstam MA,Neaton JD,Poole-Wilson PA,et al.ELITE Ⅱ Investigators.Comparison of losartan and captopril on heart failurerelated outcomes and symptoms from the losartan heart failure survival study (ELITE Ⅱ).Am Heart J,2005,150:123-131.
  • 5[5]Horwich TB,MacLellan WR,Fonarow GC.Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.J Am Coll Cardiol,2004,43:642-668.
  • 6[6]Hognestad A,Dickstein K,Myhre E,et al.The OPTIMAAL Investigators.Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.Am J Gardiol,2004,93:603 -606.
  • 7[7]Williams RE.Early initiation of beta blockade in heart failure:issues and evidence.J Clin Hypertens (Greenwich),2005,7:520-528; quiz 529-530.Review.
  • 8[8]Sever PS.Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.J Am Coll Cardiol,2005,46:182.
  • 9[9]Willenheimer R,van Veldhuisen DJ,Ponikowski P,et al.CIBIS-Ⅱ Steering Committee and Investigators.Lipid-lowering therapy and the patient with multiple risk factors:what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?Am J Med,2005,118 (Suppl 12A):S3-S9.
  • 10[10]Tseng KH.Reduction in cardiovascular events with atorvastatin in 2532 patients with type 2 diabetes:Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA):response to Server et al.Diabetes Care,2005,28:2595; author reply 2595-2596.

同被引文献49

  • 1赵水平.急性冠状动脉综合征患者应尽早服用他汀类药物[J].中华心血管病杂志,2004,32(11):961-962. 被引量:81
  • 2杨水祥,胡大一.心力衰竭的新机制和新策略研究进展[J].中国心血管病研究,2005,3(6):403-405. 被引量:53
  • 3李为民,孔一慧.他汀类药物治疗慢性心力衰竭的利弊探讨[J].中华心血管病杂志,2006,34(9):774-775. 被引量:28
  • 4王桂芳,陆世红,王福花,沈卫平.普伐他汀治疗扩张型心肌病的临床观察[J].临床荟萃,2007,22(5):353-355. 被引量:2
  • 5Kjekshus J,Apetrei E,Barrios V,et al.Rosuvastatin in older patients with systolic heart failure[J].N Engl J Med,2007,357 (22):2248-2261.
  • 6GISSI-HF Investigators.Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial):a randomised,double-blind,placebo-controlled trial[J].Lancet,2008,372 (9645):1231-1239.
  • 74S Group 1994.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study[J].Lancet,1994,344 (8934):1383-1389.
  • 8Spencer FA,Allegrone J,Goldberg R J,et al.Association of statin therapy with outcomes of acute coronary syndrome:the GRACE study.Ann Intern Meal,2004,140 (11):857-866.
  • 9Nakata S,Tsutsui M,Shimokawa H,et al.Statin treatmentupregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway[J].Arterioscler Thromb Vasc Biol,2007,27 (1):92-98.
  • 10Greer JJ,Kakkar AK,Elrod JW,et al.Low-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure[J].Am J Physioi Heart Circ Physiol,2006,291 (6):H2743-H2751.

引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部